More recently, several groups have shown that GR, LXR and PPAR may play distinct yet important roles in the development and progression of BRCA mutant breast cancer (195–197), suggesting that other nuclear receptors could be targeted for the prevention of breast cancer. This evidence concerns the gene NR3C1 and breast cancer.